Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations.

• Authors : Hai-Su Yang¹

Subjects: *HEMATOLOGIC malignancies; *IMMUNOHISTOCHEMISTRY; *LYMPHOPROLIFERATIVE disorders

• Source: Cancer Biomarkers. 2016, Vol. 17 Issue 4, p383-389. 7p.

Record details

NPRL2 is an independent prognostic factor of osteosarcoma.

• Authors : Gao, Yuzhong¹; Wang, Jian²; Fan, Guangyu³

Subjects: *OSTEOSARCOMA; *IMMUNOHISTOCHEMISTRY; *MULTIPLE myeloma

• Source: Cancer Biomarkers. 2013, Vol. 12 Issue 1, p31-36. 6p. 1 Color Photograph, 2 Charts, 2 Graphs.

Record details

Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.

• Authors : Mareĉko, Ilona¹; Cvejić, Dubravka¹; Tatić, Svetislav²

Subjects: *MATRIX metalloproteinases; *IMMUNOHISTOCHEMISTRY; *TISSUE inhibitors of metalloproteinases

• Source: Cancer Biomarkers. 2012, Vol. 11 Issue 1, p49-58. 10p. 2 Color Photographs, 3 Charts, 2 Graphs.

Record details

Expression and prognostic relevance of Id1 in stage III esophageal squamous cell carcinoma.

• Authors : Liu, Jingeng¹; Hu, Yi¹; Hu, Wei²

Subjects: *TUMORS; *IMMUNOHISTOCHEMISTRY; *SQUAMOUS cell carcinoma

• Source: Cancer Biomarkers. 2011, Vol. 8 Issue 2, p67-72. 6p.

Record details

Low OCEL1 expression is associated with poor prognosis in human non-small cell lung cancer

• Authors : Deng, M.^1,5,6; Zhang, Z.^1,2; Hu, X.¹

• Source: In: Cancer Biomarkers. (Cancer Biomarkers, 2020, 27(4):519-524)

Record details

ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy

• Authors : Abdelrahman, A.E.¹; Ibrahim, D.A.¹; El-Azony, A.²

• Source: In: Cancer Biomarkers. (Cancer Biomarkers, 2020, 27(2):251-264)

Record details

Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: A preliminary study of 30 cases.

• Authors : Jin-Hua Li¹; Yan-Gao Man²

Subjects: *NEPHROBLASTOMA; *IMMUNOHISTOCHEMISTRY; *DIAGNOSTIC immunohistochemistry

• Source: Cancer Biomarkers. 2009, Vol. 5 Issue 3, p109-116. 8p. 4 Color Photographs, 4 Charts.

Record details

Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.

• Authors : Masetti, Michele¹; Acquaviva, Giorgia^1,2; Visani, Michela²

Subjects: *ADENOCARCINOMA; *CANCER patients; *IMMUNOHISTOCHEMISTRY

• Source: Cancer Biomarkers. 2018, Vol. 21 Issue 2, p323-334. 12p.

Record details

Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer.

• Authors : Rong Yao¹; Juan Pu²; Ruihua Fan¹

Subjects: *ESOPHAGEAL cancer; *TISSUE arrays; *IMMUNOHISTOCHEMISTRY

• Source: Cancer Biomarkers. 2017, Vol. 20 Issue 3, p317-323. 7p.

Record details

Synergistic efficacy of Cullin1 and MMP-2 expressions in diagnosis and prognosis of colorectal cancer.

• Authors : Jianliang Deng¹; Wenjiao Chen¹; Yuan Du²

Subjects: *COLON cancer diagnosis; *MATRIX metalloproteinases; *IMMUNOHISTOCHEMISTRY

• Source: Cancer Biomarkers. 2017, Vol. 19 Issue 1, p57-64. 8p.

Record details